Amphetamine concentrations in human urine following single-dose administration of the calcium antagonist prenylamine-studies using fluorescence polarization immunoassay (FPIA) and GC-MS.
暂无分享,去创建一个
Frank T Peters | Thomas Kraemer | Hans H Maurer | F. Peters | H. Maurer | T. Kraemer | Susanne K Roditis
[1] H. Maurer. Systematic toxicological analysis of drugs and their metabolites by gas chromatography-mass spectrometry. , 1992, Journal of chromatography.
[2] H. Maurer,et al. Identification and differentiation of benzodiazepines and their metabolites in urine by computerized gas chromatography-mass spectrometry. , 1987, Journal of chromatography.
[3] H. Maurer,et al. Determination of amphetamine, methamphetamine and amphetamine-derived designer drugs or medicaments in blood and urine. , 1998, Journal of chromatography. B, Biomedical sciences and applications.
[4] H. Maurer,et al. Mass spectral and GC data of drugs, poisons, and their metabolites , 1985 .
[5] H. Maurer. On the metabolism and the toxicological analysis of methylenedioxyphenylalkylamine designer drugs by gas chromatography-mass spectrometry. , 1996, Therapeutic drug monitoring.
[6] Karl Pfleger,et al. Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites: Part 3 mass spectra (m/z222 to 777 amu). , 1992 .
[7] R. Bayer,et al. Basic mechanisms underlying prenylamine-induced 'torsade de pointes': differences between prenylamine and fendiline due to basic actions of the isomers. , 1988, Current medical research and opinion.
[8] H. Maurer,et al. Mass spectral and GC data of drugs, poisons, pesticides, pollutants and their metabolites. Part 1: methods, tables, indexes. , 1992 .
[9] E. Mutschler,et al. Single- and multiple-dose pharmacokinetics of R-(−)- and S-(+)-prenylamine in man , 2004, European Journal of Clinical Pharmacology.
[10] Thomas Layloff,et al. Analytical Methods Validation: Bioavailability, Bioequivalence and Pharmacokinetic Studies , 1992, Pharmaceutical Research.
[11] H. Maurer,et al. Identification and differentiation of beta-blockers and their metabolites in urine by computerized gas chromatography-mass spectrometry. , 1986, Journal of chromatography.
[12] A. Fleckenstein. History of Calcium Antagonists , 1983, Circulation research.
[13] H. Maurer. Identification and differentiation of barbiturates, other sedative-hypnotics and their metabolites in urine integrated in a general screening procedure using computerized gas chromatography-mass spectrometry. , 1990, Journal of chromatography.
[14] Vinod P. Shah,et al. Bioanalytical Method Validation—A Revisit with a Decade of Progress , 2000, Pharmaceutical Research.
[15] H. Maurer,et al. Screening procedure for detection of antidepressants of the selective serotonin reuptake inhibitor type and their metabolites in urine as part of a modified systematic toxicological analysis procedure using gas chromatography-mass spectrometry. , 2000, Journal of analytical toxicology.
[16] H. Maurer,et al. Screening procedures for simultaneous detection of several drug classes used for high throughput toxicological analyses and doping control. A review. , 2000, Combinatorial chemistry & high throughput screening.
[17] C. J. Schmitt,et al. Gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS) in toxicological analysis. Studies on the detection of clobenzorex and its metabolites within a systematic toxicological analysis procedure by GC-MS and by immunoassay and studies on the detection of alp , 1997, Journal of chromatography. B, Biomedical sciences and applications.
[18] M. Lehmann,et al. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. , 1993, JAMA.
[19] I. Vernaleken,et al. Studies on the metabolism and toxicological detection of the amphetamine-like anorectic mefenorex in human urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay. , 1997, Journal of chromatography. B, Biomedical sciences and applications.
[20] M. Eichelbaum,et al. Metabolism of DL-[14C]prenylamine in man. , 1977, Biomedical mass spectrometry.
[21] H. Maurer,et al. Screening for Detection of New Antidepressants, Neuroleptics, Hypnotics, and Their Metabolites in Urine by GC-MS Developed Using Rat Liver Microsomes , 2001, Therapeutic drug monitoring.
[22] H. Maurer,et al. Screening procedure for the detection of opioids, other potent analgesics and their metabolites in urine using a computerized gas chromatographic-mass spectrometric technique , 1984 .
[23] H. Maurer,et al. Toxicological detection of pholcodine and its metabolites in urine and hair using radio immunoassay, fluorescence polarisation immunoassay, enzyme immunoassay and gas chromatography-mass spectrometry , 2005, International Journal of Legal Medicine.
[24] A. Vermeulen,et al. Double-Blind Comparison of Prenylamine and Penbutolol in Patients with Angina Pectoris , 1985, The Journal of international medical research.
[25] K. Kovar,et al. Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, "Eve") and its metabolites in urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay. , 1996, Journal of chromatography. B, Biomedical applications.
[26] Thomas Layloff,et al. Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies , 1992 .